Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Larkin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bio-Protocol|March 4, 2021
Phototactic T-maze Behavioral Assay for Comparing the Functionality of Color-sensitive Photoreceptor Subtypes in the <i>Drosophila</i> Visual SystemHunter S Shaw, Joe Larkin, Yong Rao
Physics in Medicine and Biology|September 21, 2016
A 4D biomechanical lung phantom for joint segmentation/registration evaluationDaniel Markel, Ives Levesque, Joe Larkin, et al.
Journal of Applied Clinical Medical Physics|March 7, 2006
Total body irradiation with a reconditioned cobalt teletherapy unitMichael D C Evans, Renée-Xavière Larouche, Marina Olivares, et al.
Investigational New Drugs|August 10, 2011
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumorsJ Paul Monk, Miguel Villalona-Calero, Joe Larkin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bio-Protocol|March 4, 2021
Phototactic T-maze Behavioral Assay for Comparing the Functionality of Color-sensitive Photoreceptor Subtypes in the <i>Drosophila</i> Visual SystemHunter S Shaw, Joe Larkin, Yong Rao
Physics in Medicine and Biology|September 21, 2016
A 4D biomechanical lung phantom for joint segmentation/registration evaluationDaniel Markel, Ives Levesque, Joe Larkin, et al.
Journal of Applied Clinical Medical Physics|March 7, 2006
Total body irradiation with a reconditioned cobalt teletherapy unitMichael D C Evans, Renée-Xavière Larouche, Marina Olivares, et al.
Investigational New Drugs|August 10, 2011
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumorsJ Paul Monk, Miguel Villalona-Calero, Joe Larkin, et al.
Pageof 1